Drug and light dose responses to focal photodynamic therapy of single blood vessels in vivo

Journal of Biomedical Optics

Volumn 14, Issue 6, 2009, Pages

  Khurana, Mamta ^a   Moriyama, Eduardo H ^a   Mariampillai, Adrian ^a   Samkoe, Kimberley ^b   Cramb, David ^c   Wilson, Brian C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b DARTMOUTH COLLEGE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Age related macular degeneration; Blood vessel; Confocal microscopy; Drug light product; Fluorescence; Photodynamic therapy; Two photon; Verteporfin; Window chamber mouse

Indexed keywords

AGE-RELATED MACULAR DEGENERATION; DRUG-LIGHT PRODUCT; TWO PHOTON; VERTEPORFIN; WINDOW CHAMBER MOUSE;

BLOOD; CONFOCAL MICROSCOPY; DRUG DOSAGE; FOCUSING; IRRADIATION; MAMMALS; OPHTHALMOLOGY; PHOTODYNAMIC THERAPY; PHOTONS; PHOTOSENSITIZERS; PLASMONS; PORPHYRINS;

BLOOD VESSELS;

MURINAE;

PHOTOSENSITIZING AGENT; PORPHYRIN; VERTEPORFIN;

ANIMAL; ARTICLE; BLOOD VESSEL; CONFOCAL MICROSCOPY; CYTOCHEMISTRY; DOSE RESPONSE; DRUG EFFECT; METHODOLOGY; MOUSE; NUDE MOUSE; PHOTOCHEMOTHERAPY; PHYSIOLOGY; RADIATION RESPONSE; RETINA MACULA DEGENERATION; SPECTROFLUOROMETRY;

ANIMALS; BLOOD VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HISTOCYTOCHEMISTRY; MACULAR DEGENERATION; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SPECTROMETRY, FLUORESCENCE;

EID: 77950360686     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3262521     Document Type: Article

References (59)

1. O. Raab, "On the effect of fluorescent substances on infusoria (in German)," Z. Biol. 39, 524-546 (1900).
2. J. D. Spikes, "The historical development of ideas on applications of photosensitizer reactions to the health sciences," in Primary Photoprocess in Biology and Medicine, R. V. Bensasson, G. Jori, E. Land, and T. G. Truscott, Editors., pp. 209-227, Plenum Press, New York (1985).
3. R. L. Lipson and E. J. Baldes, "The photodynamic properties of a particular hematoporphyrin derivative," Arch. Dermatol. 82, 508-516 (1960).
4. T. J. Dougherty, B. Henderson, S. Schwartz, J. W. Winkelman, and R. L. Lipson, "Historical perspective in photodynamic therapy," in Photodynamic Therapy, B. W. Henderson and T. J. Dougherty, Eds., pp. 1-18, Marcel Dekker, New York (1992).
5. T. J. Dougherty, J. E. Kaufman, A. Goldfarb, K. R. Weishaupt, D. Boyle, and A. Mittleman, "Photoradiation therapy for the treatment of malignant tumors," Cancer Res. 38, 2628-2635 (1978). (Pubitemid 8390848)
6. M. A. Awan and S. A. Tarin, "Review of photodynamic therapy," Surgeon 4, 231-236 (2006). (Pubitemid 44165024)
7. V. H. Fingar, "Vascular effects of photodynamic therapy," J. Clin. Laser Med. Surg. 14, 323-328 (1996). (Pubitemid 26405724)
8. B. Krammer, "Vascular effects of photodynamic therapy," Anticancer Res. 21, 4271-4277 (2001). (Pubitemid 34245368)
9. J. Trachtenberg, R. A. Weersink, S. R. H. Davidson, M. A. Haider, A. Bogaards, M. R. Gertner, A. Evans, A. Scherz, J. Savard, J. L. Chin, B. C. Wilson, and M. Elhilali, "Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses," BJU Int. 102, 556-562 (2008).
10. B. Furie and B. C. Furie, "In vivo thrombus formation," J. Thromb. Haemost. 5, 12-17 (2007). (Pubitemid 46958811)
11. L. Sikora, A. C. Johansson, S. P. Rao, G. K. Hughes, D. H. Broide, and P. Sriramarao, "A murine model to study leukocyte rolling and intravascular trafficking in lung microvessels," Am. J. Pathol. 162, 2019-2028 (2003). (Pubitemid 36613058)
12. S. Falati, P. Gross, G. Merrill-Skoloff, B. C. Furie, and B. Furie, "Real-time in vivo imaging of platelets, tissue factor, and fibrin during arterial thrombus formation in the mouse," Nat. Med. 8, 1175-1181 (2002).
13. H. Sorg, J. N. Hoffmann, R. E. Rumbaut, M. D. Menger, N. Lindenblatt, and B. Vollmar, "Efficacy of antithrombin in the prevention of microvascular thrombosis during endotoxemia: an intravital microscopic study," Thromb. Res. 121, 241-248 (2007). (Pubitemid 350138077)
14. M. Khurana, E. H. Moriyama, A. Mariampillai, and B. C. Wilson, "Intravital high resolution optical imaging of individual vessel response to photodynamic treatment," J. Biomed. Opt. 13, 040502 (2008).
15. Verteporfin Roundtable 2000 and 2001 Participants, "Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes," Retina 22, 6-18 (2002).
16. M. Waisbourd, A. Loewenstein, M. Goldstein, and I. Leibovitch, "Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration," Drugs Aging 24, 643-662 (2007).
17. V. Chaudhary, A. Mao, P. L. Hooper, and T. G. Sheidow, "Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial," Ophthalmology 114, 2183-2189 (2007). (Pubitemid 350181099)
18. J. Bradley, M. Ju, and G. S. Robinson, "Combination therapy for the treatment of ocular neovascularization," Angiogenesis 10, 141-148 (2007). (Pubitemid 46440632)
19. M. Ju, C. Mailhos, J. Bradley, T. Dowie, M. Ganley, G. Cook, P. Calias, N. Lange, A. P. Adamis, D. T. Shima, and G. S. Robinson, "Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization," Invest. Ophthalmol. Vis. Sci. 49, 662-670 (2008).
20. D. N. Zacks, E. Ezra, Y. Terada, N. Michaud, E. Connolly, E. S. Gragoudas, and J. W. Miller, "Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization," Invest. Opthalmol. Vis. Sci. 43, 2384-2391 (2002). (Pubitemid 34700672)
21. M. H. Reinke, C. Canakis, D. Husain, N. Michaud, T. J. Flotte, E. S. Gragoudas, and J. W. Miller, "Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey," Ophthalmology 106, 1915-1923 (1999).
22. A. Karotki, M. Khurana, J. R. Lepock, and B. C. Wilson, "Simultaneous two-photon excitation of Photofrin in relation to photodynamic therapy," Photochem. Photobiol. 82, 443-452 (2006).
23. K. S. Samkoe and D. T. Cramb, "Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration," J. Biomed. Opt. 8, 410-417 (2003).
24. R. M. Williams, D. W. Piston, and W. W. Webb, "Two-photon molecular excitation provides intrinsic 3-dimensional resolution for laser-based microscopy and microphotochemistry," FASEB J. 8, 804-813 (1994). (Pubitemid 24268871)
25. M. Oheim, D. J. Michael, M. Geisbauer, D. Madsen, and R. H. Chow, "Principles of two-photon excitation fluorescence microscopy and other nonlinear imaging approaches," Adv. Drug Delivery Rev. 58, 788-808 (2006). (Pubitemid 44794344)
26. I. Kozak, L. Cheng, D. E. Cochran, and W. R. Freeman, "Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularization in age related macular degeneration," Br. J. Ophthamol. 90, 1152-1156 (2006). (Pubitemid 44351148)
27. H. A. Collins, M. Khurana, E. H. Moriyama, A. Mariampillai, E. Dahlstedt, M. Balaz, M. K. Kuimova, M. Drobizhev, V. X. D. Yang, D. Phillips, A. Rebane, B. C. Wilson, and H. L. Anderson, "Blood vessel closure using photosensitizers engineered for two-photon excitation," Nat. Photonics 2, 420-424 (2008).
28. G. H. Algire and F. Y. Legallais, "Recent developments in the transparent-chamber technique as adapted to the mouse," J. Natl. Cancer Inst. (1940-1978) 10, 225-253 (1949).
29. V. H. Fingar, W. R. Potter, and B. W. Henderson, "Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes," Photochem. Photobiol. 45, 643-650 (1987).
30. V. H. Fingar and B. W. Henderson, "Drug and light dose dependence of photodynamic therapy: A study of tumor and normal tissue response," Photochem. Photobiol. 46, 837-841 (1987).
31. R. L. Goyan and D. T. Cramb, "Near-infrared two-photon excitation of protoporphyrin IX: photodynamics and photoproduct generation," Photochem. Photobiol. 72, 821-827 (2000).
32. M. Khurana, H. A. Collins, A. Karotki, H. L. Anderson, D. T. Cramb, and B. C. Wilson, "Quantitative in vitro demonstration of two-photon photodynamic therapy using Photofrin and Visudyne," Photochem. Photobiol. 83, 1441-1448 (2007). (Pubitemid 350132612)
33. A. Mariampillai, B. A. Standish, E. H. Moriyama, M. Khurana, N. R. Munce, M. K. Leung, J. Jiang, A. Cable, B. C. Wilson, A. I. Vitkin, and V. X. Yang, "Speckle variance detection of microvasculature using swept-source optical coherence tomography," Opt. Lett. 33, 1530-1532 (2008).
34. S. O. Gollnick, S. S. Evans, H. Baumann, B. Owczarczak, P. Maier, L. Vaughan, W. C. Wang, E. Unger, and B. W. Henderson, "Role of cytokines in photodynamic therapy-induced local and systemic inflammation," Br. J. Cancer 88, 1772-1779 (2003). (Pubitemid 36760423)
35. B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan, "Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy in tumors," Cancer Res. 64, 2120-2126 (2004). (Pubitemid 38339462)
36. K. S. Samkoe, "Two-photon excitation photodynamic therapy: progress towards a new treatment for wet age-related macular degeneration," PhD Thesis, Department of Chemistry, University of Calgary (2007).
37. K. S. Samkoe, A. Clancy, A. Karotki, B. C. Wilson, and D. T. Cramb, "Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration," J. Biomed. Opt. 12, 034025 (2007).
38. V. H. Fingar, S. W. Taber, P. S. Haydon, L. T. Harrison, S. J. Kempf, and T. J. Wieman, "Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in preclinical and clinical models at the University of Louisville," Rev. Gastroenterol. Peru 14, 93-100 (2000). (Pubitemid 30189217)
39. D. K. Kelleher, O. Thews, A. Scherz, Y. Salomon, and P. Vaupel, "Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pdbacteriopheophorbide," Int. J. Oncol. 24, 1505-1511 (2004).
40. S. L. Gibson and R. Hilf, "Interdependence of fluence, drug dose and oxygen on hematoporphyrin derivative induced photosensitization of tumor mitochondria," Photochem. Photobiol. 42, 367-373 (1985).
41. B. W. Henderson, D. A. Bellnier, B. Ziring, and T. J. Dougherty, "Aspects of the cellular uptake and retention of hematoporphyrin derivative and their correlation with the biological response to PRT in vitro," in Porphyrin Photosensitization, D. Kessel and T. J. Dougherty, Eds., pp. 129-138, New York, Plenum Press (1983).
42. W. M. Star, H. P. A. Marijnissen, A. E. van den Berg-Blok, J. A. C. Versteeg, K. A. P. Franken, and H. S. Reinhold, "Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers," Cancer Res. 46, 2532-2540 (1986). (Pubitemid 16120726)
43. M. W. Reed, T. J. Wieman, D. A. Schuschke, M. T. Tseng, and F. N. Miller, "A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation," Radiat. Res. 119, 542-552 (1989). (Pubitemid 19234980)
44. V. H. Fingar, T. J. Wieman, S. A. Wiehle, and P. B. Cerrito, "The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion," Cancer Res. 52, 4914-4921 (1992).
45. V. H. Fingar, T. J. Wieman, and P. S. Haydon, "The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using Photofrin," Photochem. Photobiol. 66, 513-517 (1997). (Pubitemid 127470199)
46. V. H. Fingar, P. K. Kik, P. S. Haydon, P. B. Cerrito, M. Tseng, E. Abang, and T. J. Wieman, "Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)," Br. J. Cancer 79, 1702-1708 (1999). (Pubitemid 29132292)
47. V. H. Fingar, K. A. Siegel, T. J. Wieman, and K. W. Doak, "The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy," Photochem. Photobiol. 58, 393-399 (1993).
48. M. O. Dereski, C. Hopp, Q. Chen, and F. W. Hetzel, "Normal brain tissue response to photodynamic therapy: histology, vascular permeability and specific gravity," Photochem. Photobiol. 50, 653-657 (1989).
49. M. Korbelik, "PDT-associated host response and its role in the therapy outcome," Lasers Surg. Med. 38, 500-508 (2006).
50. I. Cecic, C. S. Parkins, and M. Korbelik, "Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors," Photochem. Photobiol. 74, 712-720 (2001).
51. J. Sun, I. Cecic, C. S. Parkins, and M. Korbelik, "Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours," Photochem. Photobiol. Sci. 1, 690-695 (2002). (Pubitemid 37069785)
52. M. A. Middelkamp-Hup, I. Sánchez-Carpintero, S. Kossodo, P. Waterman, S. González, M. C. Mihm Jr., and R. R. Anderson, "Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model," J. Invest. Dermatol. 121, 634-639 (2003). (Pubitemid 37072279)
53. J. W. Miller, "Higher irradiance and photodynamic therapy for agerelated macular degeneration," Trans.-Am. Acad. Opthalmol. Otolayngol., Sec. Ophthalmol. 106, 357-382 (2008).
54. P. Nowak-Sliwinska, A. Karocki, M. Elas, A. Pawlak, G. Stochel, and K. Urbanska, "Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells," Biochem. Biophys. Res. Commun. 349, 549-555 (2006). (Pubitemid 44344555)
55. B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes, and T. Hasan, "Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications," Clin. Cancer Res. 12, 917-923 (2006). (Pubitemid 43259874)
56. R. W. Flower, "Optimizing treatment of choroidal neovascularization feeder vessels associated with age-related macular degeneration," Am. J. Ophthalmol. 134, 228-239 (2002). (Pubitemid 34831827)
57. G. Staurenghi, N. Orzalesi, A. La Capria, and M. Aschero, "Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography," Ophthalmology 105, 2297-2305 (1998). (Pubitemid 30191675)
58. Y. Wang, A. Lu, J. Gil-Flamer, O. Tan, J. A. Izatt, and D. Huang, "Measurement of total blood flow in the normal human retina using Doppler Fourier-domain optical coherence tomography," Br. J. Ophthamol. 93, 634-637 (2009).
59. M. E. J. van Velthoven, D. J. Faber, F. D. Verbraak, T. G. van Leeuwen, and M. D. de Smet, "Recent developments in optical coherence tomography for imaging the retina," Prog. Retin Eye Res. 26, 57-77 (2007). (Pubitemid 44894994)